Eli Lilly and Company is collaborating with Nvidia and OpenAI to build an AI lab aimed at accelerating drug discovery.
3 reports, 3 independent
Updated Aug 31
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly and Company is collaborating with Nvidia and OpenAI to build an AI lab aimed at accelerating drug discovery.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.The partnership is expanding into AI drug discovery initiatives, including developing Jalapeno silicon and predicting market shifts.1 source
Lilly is partnering with Nvidia and OpenAI to use AI for faster drug development.1 source
Nvidia and OpenAI are partnering with Eli Lilly to advance drug discovery using AI.1 source
Keep exploring
The entities involved
-
Nvidia
American multinational technology company
-
Eli Lilly and Company
American pharmaceutical company
-
OpenAI
American artificial intelligence research organization
- Leaders call for international cooperation on AI risks, tech leaders call for oversight, and the CMA proposes stricter search engine choice requirements.
- Experts, including Dario Amodei at Cornell University, warned about the power and limits of AI, specifically citing risks of AI taking control of the internet.
Related events
- OpenAI, Google, Meta, and Nvidia are identified as major players and leading labs in the competitive AI industry.
- Anthropic and Novartis are collaborating on preclinical drug discovery programs, while the rivalry between AI firms drives market focus.
- Nvidia, OpenAI, and Alphabet Inc. are major players in the AI infrastructure race, with Nvidia contributing $30 billion to a funding round.
- Nvidia and Hoffmann-La Roche share interest in AI-driven therapeutics following the establishment of a new innovation center in Boston.
- Nvidia announced a new financing setup designed to support various AI companies, including Anthropic and OpenAI.